2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol manufacturers
- Gnetol
-
- $54.00 / 5mg
-
2026-03-06
- CAS:86361-55-9
- Min. Order:
- Purity: 99.84%
- Supply Ability: 10g
- Gnetol
-
- $15.00 / 1KG
-
2021-07-02
- CAS:86361-55-9
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
| | 2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Basic information |
| Product Name: | 2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol | | Synonyms: | 2-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol;2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol;Gnetol;2,3',5',6-Tetrahydroxy-trans-stilbene;-2-(3,5-Dihydroxystyryl);Gnetol>(E)-2-(3,5-Dihydroxystyryl)benzene-1,3-diol;1,3-Benzenediol, 2-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]- | | CAS: | 86361-55-9 | | MF: | C14H12O4 | | MW: | 244.24 | | EINECS: | 617-839-9 | | Product Categories: | | | Mol File: | 86361-55-9.mol | ![2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Structure](CAS2/GIF/86361-55-9.gif) |
| | 2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Chemical Properties |
| Melting point | 271°C(lit.) | | Boiling point | 540.8±30.0 °C(Predicted) | | density | 1.468±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | pka | 9.06±0.40(Predicted) | | form | powder to crystal | | color | White to Light yellow to Light orange | | λmax | 337nm(EtOH)(lit.) | | CAS DataBase Reference | 86361-55-9 |
| | 2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Usage And Synthesis |
| Uses | Gnetol (cas# 86361-55-9) is a compound useful in organic synthesis. | | in vivo | Male Sprague-Dawley rats were cannulated and dosed either intravenously with Gnetol (10μg/kg) or orally (100mg/kg). After oral and intravenous administration, Gnetol is detected in both serum and urine as the parent compound and as a glucuronidated metabolite. The bioavailability of Gnetol is determined to be 6%. Gnetol is rapidly glucuronidated and is excreted in urine and via nonrenal routes[1].
Pretreatment of Male NIH Swiss mice (20-35 g) with Gnetol (50mg/kg, SC) is able to increase the latency period to response in analgesia models[1]. | | target | Tyrosinase | BACE | | IC 50 | COX-1: 0.78 μM (IC50); Tyrosinase: 4.5 μM (IC50); HDAC |
| | 2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Preparation Products And Raw materials |
|